L-Lactic Acid

L-Lactic Acid

SCHEMBL29401074

C[C@H](O)C(=O)[O-].C[C@H](O)C(=O)[O-].O.O.[Zn+2]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3

The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.47
CA1 P00915 4/20 0.38
CA4 P22748 3/20 0.36
CA2 P00918 1/20 0.36
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
NFKB1 P19838 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Lactic Acid SCHEMBL1229932 1.00 TP53 (0.47) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL15362198 1.00 TP53 (0.47) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL435503 1.00 TP53 (0.47) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL118974 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL29397605 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL29397432 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL28619730 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL975525 0.96 TP53 (0.50) TP53CA1CA4CA2CYP3A4
L-Lactic Acid SCHEMBL25270068 0.93
L-Lactic Acid SCHEMBL8462013 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608359-A1 MOUTHWASH COMPOSITIONS AND METHODS Colgate-Palmolive Company (US) 2025-09-03 EP claimed
US-20240197600-A1 Mouthwash Compositions and Methods COLGATE-PALMOLIVE COMPANY 2024-06-20 US claimed
WO-2024123885-A1 MOUTHWASH COMPOSITIONS AND METHODS COLGATE-PALMOLIVE COMPANY (US) 2024-06-13 WO claimed
EP-4608359-A1 MOUTHWASH COMPOSITIONS AND METHODS Colgate-Palmolive Company (US) 2025-09-03 EP disclosed
CN-119792104-A Oral care compositions 高露洁-棕榄公司 2025-04-11 CN disclosed
US-20240197600-A1 Mouthwash Compositions and Methods COLGATE-PALMOLIVE COMPANY 2024-06-20 US disclosed
WO-2024123885-A1 MOUTHWASH COMPOSITIONS AND METHODS COLGATE-PALMOLIVE COMPANY (US) 2024-06-13 WO disclosed
EP-3519060-B1 ORAL CARE COMPOSITIONS WITH INCREASED WHITENING EFFICACY COLGATE PALMOLIVE CO (US) 2022-12-14 EP disclosed
US-20220133607-A1 Oral Care Composition COLGATE-PALMOLIVE COMPANY (US) 2022-05-05 US disclosed
US-11253444-B2 Oral care composition COLGATE-PALMOLIVE COMPANY (US) 2022-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197600-A1 Mouthwash Compositions and Methods TREH, CD44, GLA TP53 1297/4885CA1 1811/4885CA4 1501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.